Iron metabolism in Parkinsonian syndromes
Identifieur interne : 000323 ( Istex/Curation ); précédent : 000322; suivant : 000324Iron metabolism in Parkinsonian syndromes
Auteurs : Daniela Berg [Allemagne] ; Helmine Hochstrasser [Allemagne]Source :
- Movement Disorders [ 0885-3185 ] ; 2006-09.
English descriptors
Abstract
Growing evidence suggests an involvement of iron in the pathophysiology of neurodegenerative diseases. Several of the diseases are associated with parkinsonian syndromes, induced by degeneration of basal ganglia regions that contain the highest amount of iron within the brain. The group of neurodegenerative disorders associated with parkinsonian syndromes with increased brain iron content can be devided into two groups: (1) parkinsonian syndromes associated with brain iron accumulation, including Parkinson's disease, diffuse Lewy body disease, parkinsonian type of multiple system atrophy, progressive supranuclear palsy, corticobasal ganglionic degeneration, and Westphal variant of Huntington's disease; and (2) monogenetically caused disturbances of brain iron metabolism associated with parkinsonian syndromes, including aceruloplasminemia, hereditary ferritinopathies affecting the basal ganglia, and panthotenate kinase associated neurodegeneration type 2. Although it is still a matter of debate whether iron accumulation is a primary cause or secondary event in the first group, there is no doubt that iron‐induced oxidative stress contributes to neurodegeneration. Parallels concerning pathophysiological as well as clinical aspects can be drawn between disorders of both groups. Results from animal models and reduction of iron overload combined with at least partial relief of symptoms by application of iron chelators in patients of the second group give hope that targeting the iron overload might be one possibility to slow down the neurodegenerative cascade also in the first group of inevitably progressive neurodegenerative disorders. © 2006 Movement Disorder Society
Url:
DOI: 10.1002/mds.21020
Links toward previous steps (curation, corpus...)
- to stream Istex, to step Corpus: Pour aller vers cette notice dans l'étape Curation :000323
Links to Exploration step
ISTEX:8F13430A4CD3F91CE8848335C9569F986FA40475Le document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">Iron metabolism in Parkinsonian syndromes</title><author><name sortKey="Berg, Daniela" sort="Berg, Daniela" uniqKey="Berg D" first="Daniela" last="Berg">Daniela Berg</name><affiliation wicri:level="1"><mods:affiliation>Hertie Institute of Clinical Brain Research and Department of Medical Genetics, University of Tübingen, Germany</mods:affiliation><country xml:lang="fr">Allemagne</country><wicri:regionArea>Hertie Institute of Clinical Brain Research and Department of Medical Genetics, University of Tübingen</wicri:regionArea></affiliation></author><author><name sortKey="Hochstrasser, Helmine" sort="Hochstrasser, Helmine" uniqKey="Hochstrasser H" first="Helmine" last="Hochstrasser">Helmine Hochstrasser</name><affiliation wicri:level="1"><mods:affiliation>Department of Medical Genetics, University of Tübingen, Germany</mods:affiliation><country xml:lang="fr">Allemagne</country><wicri:regionArea>Department of Medical Genetics, University of Tübingen</wicri:regionArea></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">ISTEX</idno><idno type="RBID">ISTEX:8F13430A4CD3F91CE8848335C9569F986FA40475</idno><date when="2006" year="2006">2006</date><idno type="doi">10.1002/mds.21020</idno><idno type="url">https://api.istex.fr/document/8F13430A4CD3F91CE8848335C9569F986FA40475/fulltext/pdf</idno><idno type="wicri:Area/Istex/Corpus">000323</idno><idno type="wicri:Area/Istex/Curation">000323</idno></publicationStmt><sourceDesc><biblStruct><analytic><title level="a" type="main" xml:lang="en">Iron metabolism in Parkinsonian syndromes</title><author><name sortKey="Berg, Daniela" sort="Berg, Daniela" uniqKey="Berg D" first="Daniela" last="Berg">Daniela Berg</name><affiliation wicri:level="1"><mods:affiliation>Hertie Institute of Clinical Brain Research and Department of Medical Genetics, University of Tübingen, Germany</mods:affiliation><country xml:lang="fr">Allemagne</country><wicri:regionArea>Hertie Institute of Clinical Brain Research and Department of Medical Genetics, University of Tübingen</wicri:regionArea></affiliation></author><author><name sortKey="Hochstrasser, Helmine" sort="Hochstrasser, Helmine" uniqKey="Hochstrasser H" first="Helmine" last="Hochstrasser">Helmine Hochstrasser</name><affiliation wicri:level="1"><mods:affiliation>Department of Medical Genetics, University of Tübingen, Germany</mods:affiliation><country xml:lang="fr">Allemagne</country><wicri:regionArea>Department of Medical Genetics, University of Tübingen</wicri:regionArea></affiliation></author></analytic><monogr></monogr><series><title level="j">Movement Disorders</title><title level="j" type="sub">Official Journal of the Movement Disorder Society</title><title level="j" type="abbrev">Mov. Disord.</title><idno type="ISSN">0885-3185</idno><idno type="eISSN">1531-8257</idno><imprint><publisher>Wiley Subscription Services, Inc., A Wiley Company</publisher><pubPlace>Hoboken</pubPlace><date type="published" when="2006-09">2006-09</date><biblScope unit="vol">21</biblScope><biblScope unit="issue">9</biblScope><biblScope unit="page" from="1299">1299</biblScope><biblScope unit="page" to="1310">1310</biblScope></imprint><idno type="ISSN">0885-3185</idno></series><idno type="istex">8F13430A4CD3F91CE8848335C9569F986FA40475</idno><idno type="DOI">10.1002/mds.21020</idno><idno type="ArticleID">MDS21020</idno></biblStruct></sourceDesc><seriesStmt><idno type="ISSN">0885-3185</idno></seriesStmt></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>basal ganglia dysfunction</term><term>brain iron metabolism</term><term>neurodegenerative disorders</term></keywords></textClass><langUsage><language ident="en">en</language></langUsage></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Growing evidence suggests an involvement of iron in the pathophysiology of neurodegenerative diseases. Several of the diseases are associated with parkinsonian syndromes, induced by degeneration of basal ganglia regions that contain the highest amount of iron within the brain. The group of neurodegenerative disorders associated with parkinsonian syndromes with increased brain iron content can be devided into two groups: (1) parkinsonian syndromes associated with brain iron accumulation, including Parkinson's disease, diffuse Lewy body disease, parkinsonian type of multiple system atrophy, progressive supranuclear palsy, corticobasal ganglionic degeneration, and Westphal variant of Huntington's disease; and (2) monogenetically caused disturbances of brain iron metabolism associated with parkinsonian syndromes, including aceruloplasminemia, hereditary ferritinopathies affecting the basal ganglia, and panthotenate kinase associated neurodegeneration type 2. Although it is still a matter of debate whether iron accumulation is a primary cause or secondary event in the first group, there is no doubt that iron‐induced oxidative stress contributes to neurodegeneration. Parallels concerning pathophysiological as well as clinical aspects can be drawn between disorders of both groups. Results from animal models and reduction of iron overload combined with at least partial relief of symptoms by application of iron chelators in patients of the second group give hope that targeting the iron overload might be one possibility to slow down the neurodegenerative cascade also in the first group of inevitably progressive neurodegenerative disorders. © 2006 Movement Disorder Society</div></front></TEI></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/Istex/Curation
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000323 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Istex/Curation/biblio.hfd -nk 000323 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Santé
|area= MovDisordV3
|flux= Istex
|étape= Curation
|type= RBID
|clé= ISTEX:8F13430A4CD3F91CE8848335C9569F986FA40475
|texte= Iron metabolism in Parkinsonian syndromes
}}
| This area was generated with Dilib version V0.6.23. |  |